Absorption is lower than injection, but the peptide reaches target dermal tissue directly and there's no needle
With Epithalon, we take a targeted approach to longevity that goes beyond surface beauty, helping you feel younger, live healthier, and age with confidence
In SURMOUNT-1 , a 72-week Phase 3 double-blind trial in 2,539 adults with obesity (or overweight with a complication) but without diabetes, once-weekly tirzepatide produced mean weight changes of 15.0% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) versus 3.1% with placebo, with 5057% of participants on the higher doses losing at least 20% of body weight
Cyanocobalamin includes a trace cyanide component, but its clinically insignificant in therapeutic doses and quickly cleared